Detalhe da pesquisa
1.
Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms.
Breast Cancer Res
; 25(1): 123, 2023 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37817263
2.
Breast cancer hypoxia in relation to prognosis and benefit from radiotherapy after breast-conserving surgery in a large, randomised trial with long-term follow-up.
Br J Cancer
; 126(8): 1145-1156, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35140341
3.
Proteogenomic Workflow Reveals Molecular Phenotypes Related to Breast Cancer Mammographic Appearance.
J Proteome Res
; 20(5): 2983-3001, 2021 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33855848
4.
Molecular analyses of triple-negative breast cancer in the young and elderly.
Breast Cancer Res
; 23(1): 20, 2021 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33568222
5.
The PROCEM study protocol: Added value of preoperative contrast-enhanced mammography in staging of malignant breast lesions - a prospective randomized multicenter study.
BMC Cancer
; 21(1): 1115, 2021 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34663236
6.
A Targeted Mass Spectrometry Strategy for Developing Proteomic Biomarkers: A Case Study of Epithelial Ovarian Cancer.
Mol Cell Proteomics
; 18(9): 1836-1850, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31289117
7.
Added value of contrast-enhanced mammography (CEM) in staging of malignant breast lesions-a feasibility study.
World J Surg Oncol
; 18(1): 100, 2020 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32438917
8.
Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors.
Breast Cancer Res
; 20(1): 64, 2018 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29973242
9.
Cancer associated proteins in blood plasma: Determining normal variation.
Proteomics
; 16(13): 1928-37, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27121749
10.
Correction to: Molecular analyses of triple-negative breast cancer in the young and elderly.
Breast Cancer Res
; 23(1): 28, 2021 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33627140
11.
A Combined Shotgun and Targeted Mass Spectrometry Strategy for Breast Cancer Biomarker Discovery.
J Proteome Res
; 14(7): 2807-18, 2015 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25944384
12.
Changes in glycoprotein expression between primary breast tumour and synchronous lymph node metastases or asynchronous distant metastases.
Clin Proteomics
; 12(1): 13, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25991917
13.
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling.
Sci Rep
; 14(1): 6873, 2024 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38519482
14.
Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical trial.
J Immunother Cancer
; 11(5)2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37208129
15.
Proteogenomics decodes the evolution of human ipsilateral breast cancer.
Commun Biol
; 6(1): 139, 2023 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36732562
16.
Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer: a long-term follow-up of the SweBCG91RT randomized trial.
Mol Oncol
; 17(10): 2029-2040, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36975842
17.
Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial.
Clin Cancer Res
; 29(9): 1783-1793, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37071498
18.
A somatic mutation in moesin drives progression into acute myeloid leukemia.
Sci Adv
; 8(16): eabm9987, 2022 04 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35442741
19.
Histone lysine demethylase inhibition reprograms prostate cancer metabolism and mechanics.
Mol Metab
; 64: 101561, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35944897
20.
An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer.
Clin Cancer Res
; 27(20): 5557-5565, 2021 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34088723